Manhattan West Asset Management LLC Has $220,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

Manhattan West Asset Management LLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 22.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 660 shares of the company’s stock after selling 188 shares during the quarter. Manhattan West Asset Management LLC’s holdings in HCA Healthcare were worth $220,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after purchasing an additional 60,304 shares in the last quarter. Sanders Capital LLC boosted its holdings in HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after acquiring an additional 456,738 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of HCA Healthcare by 1.7% during the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after acquiring an additional 170,560 shares in the last quarter. Royal Bank of Canada grew its position in HCA Healthcare by 35.7% in the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after purchasing an additional 1,183,890 shares during the period. Finally, Capital World Investors raised its holdings in HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, SVP Kathryn A. Torres sold 1,863 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total value of $607,673.34. Following the sale, the senior vice president now directly owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the transaction, the executive vice president now directly owns 34,124 shares of the company’s stock, valued at $10,544,316. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Kathryn A. Torres sold 1,863 shares of the stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the transaction, the senior vice president now directly owns 19,612 shares in the company, valued at approximately $6,397,042.16. The disclosure for this sale can be found here. Insiders sold a total of 12,397 shares of company stock worth $3,921,929 over the last ninety days. 1.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on HCA. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Deutsche Bank Aktiengesellschaft increased their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Barclays boosted their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, Truist Financial lifted their target price on shares of HCA Healthcare from $375.00 to $390.00 and gave the stock a “buy” rating in a research report on Wednesday. Four equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $339.72.

HCA Healthcare Stock Performance

Shares of NYSE HCA traded up $1.99 during midday trading on Friday, hitting $354.78. The company’s stock had a trading volume of 1,215,941 shares, compared to its average volume of 1,679,664. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $356.30. The firm has a market capitalization of $92.92 billion, a price-to-earnings ratio of 17.69, a P/E/G ratio of 1.35 and a beta of 1.68. The company has a current ratio of 1.06, a quick ratio of 1.02 and a debt-to-equity ratio of 27.11. The stock has a fifty day moving average price of $330.12 and a 200 day moving average price of $323.11.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the business earned $4.29 earnings per share. On average, research analysts forecast that HCA Healthcare, Inc. will post 22.43 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.74%. HCA Healthcare’s payout ratio is currently 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.